ClinicalTrials.gg
Not yet recruitingNCT07803211Updated Sep 3, 2026

Evaluation of the Blunt Abdominal Trauma Severity Score (BATSS) in Blunt Abdominal Trauma

An observational study in Blunt Abdominal Trauma, Abdominal Injuries and Intra-Abdominal Injury, sponsored by Assiut University. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-03.

Sponsored by Assiut University · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
120
Ages
18 Years and older
Sex
All
01

Study summary

Blunt abdominal trauma (BAT) is a leading cause of trauma-related morbidity and mortality, commonly caused by motor vehicle collisions, falls, and assaults. Early identification of significant intra-abdominal injury remains a major diagnostic challenge because physical examination alone has limited sensitivity in patients with altered consciousness or distracting injuries.

The Blunt Abdominal Trauma Severity Score (BATSS) is a rapid bedside assessment tool that integrates clinical signs, hemodynamic parameters, and Focused Assessment with Sonography for Trauma (FAST) findings to risk-stratify patients presenting with blunt abdominal trauma.

This prospective observational cohort study aims to evaluate the diagnostic accuracy and clinical utility of BATSS in adult patients presenting with blunt abdominal trauma to the Emergency Department at Assiut University Hospitals. Enrolled participants will be scored upon initial presentation and categorized into low-, moderate-, or high-risk groups to assess the score's ability to predict the definitive mode of management (operative intervention versus conservative observation), intensive care unit (ICU) admission, in-hospital mortality, and post-traumatic complications.

02

Conditions studied

  • Blunt Abdominal Trauma
  • Abdominal Injuries
  • Intra-Abdominal Injury

Browse trials for

Keywords

  • Blunt Abdominal Trauma Severity Score
  • BATSS
  • Focused Assessment with Sonography for Trauma
  • FAST examination
  • Trauma scoring system
  • Operative management
  • Emergency trauma assessment
03

In context

Abdominal Injuries

60 studies on the registry are indexed under Abdominal Injuries; 19 are open to participants now.

This study's planned enrollment of 120 is below the median of 200 across 30 observational studies indexed under Abdominal Injuries.

Browse Abdominal Injuries studies →

Lead sponsor

Assiut University is the lead sponsor of 5,078 studies on the registry; 2,178 are open to participants now.

Of its 14 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Adult patients presenting with blunt abdominal trauma to the Emergency Department at Assiut University Hospital within 24 hours of injury.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients aged 18 years or older
  • Patients presenting with blunt abdominal trauma
  • Patients presenting within 24 hours of injury
  • Patients who undergo initial trauma assessment including Focused Assessment with Sonography for Trauma (FAST) examination
  • Patients (or their legal guardians) who provide written

Exclusion criteria

Exclusion Criteria:

  • Penetrating abdominal trauma
  • Patients younger than 18 years of age
  • Pregnant women
  • Patients referred after definitive surgical intervention at another hospital
  • Patients with incomplete clinical or radiological data
  • Patients who refuse participation
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
120 participants (estimated)
Patient registry
No

Groups and cohorts

  • Blunt Abdominal Trauma Patients

    Adult patients aged 18 years or older presenting with blunt abdominal trauma to the Emergency Department within 24 hours of injury. All enrolled patients undergo initial trauma assessment according to the ATLS protocol, including a Focused Assessment with Sonography for Trauma (FAST) examination. The Blunt Abdominal Trauma Severity Score (BATSS) is calculated upon admission to stratify patients into low-risk (\<8 points), moderate-risk (8-11 points), and high-risk (≥12 points) groups. Subsequent diagnostic evaluations (such as contrast-enhanced CT) and management pathways (operative intervention vs. conservative observation) are recorded and followed up to assess outcomes.

06

What researchers measure

Primary outcomes

  1. Number of Participants Requiring Operative Management

    Number of participants with blunt abdominal trauma who undergo surgical operative intervention (such as exploratory laparotomy) during hospitalization.

    Time frame: 7 days

07

Study locations

No study locations are listed for this record.

08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Oct 2026; primary completion for Oct 2027, 12 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 31, 2026
First posted
Sep 3, 2026
StartEst.
Oct 2026
Primary completionEst.
Oct 2027
CompletionEst.
Nov 2027
Last update
Sep 3, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 3, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07803211
Lead sponsor
Assiut University
Responsible party
Alaa Moussa Mahmoud (Resident at Emergency Department, Assiut University) — Principal investigator
First posted
Sep 3, 2026
Start date
Oct 2026 (estimated)
Primary completion
Oct 2027 (estimated)
Completion
Nov 2027 (estimated)
Last update
Sep 3, 2026
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion